Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden.

Authors	Eleni Syrimi, Sanjeeva Gunasekera, Alice Norton, Mark Velangi, Jayashree Motwani, Prashant Hiwarkar
Journal	British journal of haematology (Br J Haematol) Vol. 181 Issue 5 Pg. 696-698 (06 2018) ISSN: 1365-2141 [Electronic] England
PMID	28480955 (Publication Type: Letter)
Chemical References	rasburicase Urate Oxidase
Topics	Adolescent Child Child, Preschool Female Humans Infant Male Neoplasms (blood, therapy) Retrospective Studies Tumor Lysis Syndrome (blood, prevention & control) Urate Oxidase (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!